Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep 30;385(14):1330-1332.
doi: 10.1056/NEJMc2112981. Epub 2021 Sep 1.

Resurgence of SARS-CoV-2 Infection in a Highly Vaccinated Health System Workforce

Jocelyn Keehner  1 , Lucy E Horton  1 , Nancy J Binkin  2 , Louise C Laurent  1 ; SEARCH Alliance; David Pride  3 , Christopher A Longhurst  3 , Shira R Abeles  3 , Francesca J Torriani  3
Collaborators, Affiliations

Resurgence of SARS-CoV-2 Infection in a Highly Vaccinated Health System Workforce

Jocelyn Keehner et al. N Engl J Med. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1. SARS-CoV-2 Variants among Symptomatic Health Workers.
Shown is the distribution of the B.1.1.7 (alpha), delta, and other SARS-CoV-2 variants according to vaccination status and month of diagnosis among health workers at University of California San Diego Health, March through July 2021. The number of workers indicates those who were symptomatic and had available variant data, and the number of positive tests indicates those that included data on variants.
See this image and copyright information in PMC

Comment in

References

    1. Keehner J, Abeles SR, Torriani FJ. More on SARS-CoV-2 infection after vaccination in health care workers. reply. N Engl J Med 2021;385(2):e8. - PubMed
    1. Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med 2021;384:403-416. - PMC - PubMed
    1. Thomas SJ, Moreira ED Jr, Kitchin N, et al. Six month safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. July 28, 2021. (https://www.medrxiv.org/content/10.1101/2021.07.28.21261159v1). preprint. - DOI
    1. Lopez Bernal J, Andrews N, Gower C, et al. Effectiveness of Covid-19 vaccines against the B.1.617.2 (Delta) variant. N Engl J Med 2021;385:585-594. - PMC - PubMed
    1. Israel A, Merzon E, Schäffer AA, et al. Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection in a large cohort. August 5, 2021. (https://www.medrxiv.org/content/10.1101/2021.08.03.21261496v1). preprint. - DOI - PMC - PubMed

Publication types

Substances